Rapport Therapeutics Inc (RAPP)
EBITDA Growth
-92.87%
Quarterly · Period ending:
RAPP EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-92.87%period ending
Latest reported-92.87%period ending
RAPP Quarterly EBITDA YoY % (-227.32% → -92.87%)
Year-over-year change
High-resolution chart · PNG
RAPP ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -92.8703% | |
| 10.7058% | |
| -64.4125% | |
| -38.789% | |
| -42.0163% | |
| -58.5645% | |
| -74.3965% | |
| -124.5152% | |
| -211.5751% | |
| -227.3184% |